Search

Author/Creator Estrada, Anthony A.

2. Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond – Part 2. Issue 4 (15th February 2019)

Authors:
Shore, Daniel G.M.; Sweeney, Zachary K.; Beresford, Alan; Chan, Bryan K.; Chen, Huifen; Drummond, Jason; Gill, Andrew; Kleinheinz, Tracy; Liu, Xingrong; Medhurst, Andrew D.; McIver, Edward G.; Moffat, John G.; Zhu, Haitao; Estrada, Anthony A.
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 29:Issue 4(2019)
Page Start:
674
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo‐controlled, double‐blind phase I/Ib studies in healthy subjects and patients. Issue 8 (1st June 2022)

Authors:
Vissers, Maurits F. J. M.; Heuberger, Jules A. A. C.; Groeneveld, Geert Jan; Oude Nijhuis, Jerome; De Deyn, Peter Paul; Hadi, Salah; Harris, Jeffrey; Tsai, Richard M.; Cruz‐Herranz, Andres; Huang, Fen; Tong, Vincent; Erickson, Rebecca; Zhu, Yuda; Scearce‐Levie, Kimberly; Hsiao‐Nakamoto, Jennifer;...
Journal:
Clinical and translational science
Issue:
Volume 15:Issue 8(2022)
Page Start:
2010
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗